Hansoh Pharmaceutical Group Company Limited (HKG:3692)
32.56
-0.50 (-1.51%)
Jul 21, 2026, 4:08 PM HKT
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 197.41 billion as of July 21, 2026. Its market cap has decreased by -7.90% in one year.
Market Cap
197.41B
Enterprise Value
162.39B
Revenue
16.72B
Ranking
n/a
PE Ratio
31.50
Stock Price
32.56
ChartMarket Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 197.41B, an increase of 77.42%. That is a compound annual growth rate of 8.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 197.41B | -9.62% |
| Dec 31, 2025 | 218.43B | 113.01% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 32.38B |
| China Resources Pharmaceutical Group | 29.59B |
| China Medical System Holdings | 29.46B |
| The United Laboratories International Holdings | 18.07B |
| Grand Pharmaceutical Group | 18.07B |
| Sunshine Lake Pharma | 16.13B |
| Fujian Haixi Pharmaceuticals | 14.72B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |